Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

May 2, 2025

FORM 20-F

May 1, 2025

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

Feb 13, 2025